共 35 条
- [1] Colwell JA(1997)Aspirin therapy in diabetes Diabetes 20 1767-1771
- [2] Pearson TA(2006)Standards of care Diabetes Care 29 519-520
- [3] Blair SN(2002)AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee Circulation 106 388-391
- [4] Daniels SR(2002)Aspirin for the primary prevention of cardiovascular events: summary of the evidence Ann Intern Med 136 161-172
- [5] Anderson KM(1991)An updated coronary risk profile. A statement for health professionals Circulation 83 356-362
- [6] Wilson PW(2001)The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56) Clin Sci 101 671-679
- [7] Odell PM(2001)Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) JAMA 285 2486-2497
- [8] Kannel WB(2001)Aspirin use among adults with diabetes: estimates from the Third National Health and Nutrition Examination Survey Diabetes Care 24 197-201
- [9] Stevens RJ(2005)Progressive value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed type 2 diabetes: results from a United Kingdom study Diabet Med 22 554-562
- [10] Kothari V(2006)Coronary heart disease risk equivalence in diabetes depends on consistent risk factors Diabetes Care 29 391-397